Active, Not Recruiting
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations
NCT04695925
- Conditions
- EGFR Gene Mutation, Non-small Cell Carcinoma
- Locations
-
- Department of Medical Oncology,Cancer Center of Sun Yat-Sen University Guangzhou, Guangdong, China
- Central Hospital of Guangdong Nongken, Zhanjiang Cancer Hospital Zhanjiang, China